Pfizer
PFE
PFE
2,375 hedge funds and large institutions have $176B invested in Pfizer in 2019 Q2 according to their latest regulatory filings, with 92 funds opening new positions, 924 increasing their positions, 1,101 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
0.67% less ownership
Funds ownership: 77.49% → 76.82% (-0.67%)
1% less funds holding in top 10
Funds holding in top 10: 201 → 199 (-2)
16% less repeat investments, than reductions
Existing positions increased: 924 | Existing positions reduced: 1,101
Holders
2,375
Holding in Top 10
199
Calls
$1.74B
Puts
$1.35B
Top Buyers
| 1 | +$2.49B | |
| 2 | +$1.45B | |
| 3 | +$572M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$322M |
| 5 |
N
Natixis
Paris,
France
|
+$250M |
Top Sellers
| 1 | -$829M | |
| 2 | -$619M | |
| 3 | -$573M | |
| 4 |
Goldman Sachs
New York
|
-$536M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$306M |